CAR-T 细胞治疗后的 B 细胞缺乏:发生率、动力学、预后意义与临床管理 B Cell Aplasia Following CAR T Cell Therapy: Incidence, Kinetics, Prognostic Implications, and Clinical Management. PubMed 2026/08/19 发表Cancers (Basel)Q2 · IF 4.8(JCR 2025) 靶点:CD19靶点:BCMA技术:CAR-T急性淋巴细胞白血病慢性淋巴细胞白血病大B细胞淋巴瘤